What are the top competitors of Medartis Holding AG (SIX: MED.SW) in the Healthcare sector?

MED.SW's main Healthcare peers include Abbott Laboratories (ABT.SW), Sonova Holding AG (SOON.SW), Zimmer Biomet Holdings, Inc. (ZBH.SW), based on companies in the Medical - Devices industry.

Which has better valuations and earnings, Medartis Holding AG (SIX: MED.SW) or its competitors?

On the SIX, MED.SW trades at a P/E of 73.75 with EPS of $1.20, which can be compared directly against peers such as ABT.SW (P/E 19.79) in the table above.

Which stock is more profitable: Medartis Holding AG (SIX: MED.SW) or its competitors?

MED.SW on the SIX posts an ROE of 0.05%, versus ABT.SW's 0.11% — MED.SW shows weaker profitability than ABT.SW.

What is Medartis Holding AG's (SIX: MED.SW) stock volatility and risk?

On the SIX, MED.SW is more volatile relative to peers like ABT.SW, indicating higher risk for short-term traders.

Is Medartis Holding AG (SIX: MED.SW) stock profitable?

MED.SW on the SIX reports EPS of $1.20 and an ROE of 0.05%, indicating it is profitable.

What is Medartis Holding AG's (SIX: MED.SW) 52-week high and low?

Over the past 52 weeks, MED.SW on the SIX has traded between $70.60 and $97.50.

What was the average volume of Medartis Holding AG (SIX: MED.SW) stock?

MED.SW's average trading volume on the SIX is 6.6K.

Medartis Holding AG (SIX: MED.SW) Stock Competitors & Peer Comparison

See MED.SW's competitors and their performance on the SIX and across the wider stock market.

MED.SW●SIX

HealthcareMedical - Devices

CHF90.30

CHF2.30(2.61%)

Swiss Market opens in 13h 9m

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for MED.SW and its SIX peers.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
MED.SW	CHF 88.50	-2.10%	1.1B	75.08	CHF 1.20	N/A
ABT.SW	CHF 72.50	-2.68%	125.5B	19.79	CHF 3.66	+2.70%
SOON.SW	CHF 243.40	+0.16%	14.5B	26.84	CHF 9.10	+1.92%
ZBH.SW	CHF 62.50	-3.85%	12.1B	10.11	CHF 6.19	+1.23%

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

Abbott Laboratories (SIX: ABT.SW)

MED.SW vs ABT.SW Comparison August 2026

Medartis Holding AG (SIX: MED.SW) plays a significant role within the Healthcare sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.SW stands at 1.1B. In comparison, ABT.SW has a market cap of 125.5B. Regarding current trading prices, MED.SW is priced at CHF 88.50 on the SIX, while ABT.SW trades at CHF 72.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.SW currently has a P/E ratio of 75.08, whereas ABT.SW's P/E ratio is 19.79. In terms of profitability, MED.SW's ROE is +0.05%, compared to ABT.SW's ROE of +0.11%. Regarding short-term risk, MED.SW is more volatile compared to ABT.SW. This indicates higher risk in terms of short-term price fluctuations for MED.SW.Check ABT.SW's competition here

Medartis Holding AG (SIX: MED.SW) Stock Competitors & Peer Comparison

Peer Comparison Table: Medical - Devices Industry

Stock Comparison

Abbott Laboratories (SIX: ABT.SW)

MED.SW vs ABT.SW Comparison August 2026

Sonova Holding AG (SIX: SOON.SW)

MED.SW vs SOON.SW Comparison August 2026

Zimmer Biomet Holdings, Inc. (SIX: ZBH.SW)

MED.SW vs ZBH.SW Comparison August 2026

Stock price comparison of stocks in the Healthcare Sector

Frequently Asked Questions